This review outlines the accomplishments and potential developments of targeted alpha (α)
particle therapy (TAT). It discusses the therapeutic advantages of the short and highly …

Background Recent advances in nanotechnology have offered new hope for cancer
detection, prevention, and treatment. Nanomedicine, a term for the application of …

The present article highlights the important progress made in the last two decades in the
fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based …

Abstract Background Diffusing alpha‐emitters Radiation Therapy (“DaRT”) is a new method,
presently in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies …

The delivery of radiation therapy (RT) for cancer with intent to cure has been optimized and
standardized over the last 80 years. Both preclinical and clinical work emphasized the …

Background Diffusing alpha‐emitters radiation therapy (“DaRT”) is a new method, presently
in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies on …

Atomic in vivo nanogenerators such as actinium-225, thorium-227, and radium-223 are of
increasing interest and importance in the treatment of patients with metastatic cancer …

Glioblastoma multiforme (GBM) is at present an incurable disease with a 5-year survival rate
of 5.5%, despite improvements in treatment modalities such as surgery, radiation therapy …

Diffusing alpha-emitters radiation therapy ('DaRT') is a new cancer-treatment modality,
which enables treating solid tumors by alpha particles. The treatment utilizes implantable …

Diffusing alpha-emitting radiation therapy (DaRT) employs intratumoral Ra-224-coated
seeds that efficiently destroy solid tumors by slowly releasing alpha-emitting atoms inside …